Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil Musilek

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Medicinal Research Reviews|October 29, 2025
Human Cyclophilins-An Emerging Class of Drug TargetsKatarina Jurkova, Hana Navratilova, Kamil Musilek, et al.
Medicinal Research Reviews|June 15, 2026
Small-Molecule Kinase Inhibitors Modulating Circadian RhythmsIrene Castellino, Manuela Bartolini, Rudolf Andrys, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 30, 2006
New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarinMartina Hrabinova, Kamil Musilek, Daniel Jun, et al.
Journal of Separation Science|August 22, 2014
Structural modifications of dicationic acetylcholinesterase reactivators studied under ion-pairing mechanism in reversed-phase liquid chromatographyMedeea Radulescu, Kamil Kuca, Kamil Musilek, et al.
Behavioural Brain Research|March 18, 2014
Cholinergic antagonist 3-quinuclidinyl benzilate - Impact on learning and memory in Wistar ratsJan Misik, Jan Vanek, Kamil Musilek, et al.
Toxicology Mechanisms and Methods|August 21, 2012
The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and miceJiri Kassa, Vendula Sepsova, Kamil Musilek, et al.
Expert Opinion on Drug Discovery|September 28, 2012
The progress in the cholinesterase quantification methodsOndrej Holas, Kamil Musilek, Miroslav Pohanka, et al.
Medicinal Research Reviews|December 23, 2009
Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticidesKamil Musilek, Martin Dolezal, Frank Gunn-Moore, et al.
Drug and Chemical Toxicology|May 1, 2010
A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and miceJiri Kassa, Jana Zdarova Karasova, Kamil Kuca, et al.
Neurotoxicity Research|May 16, 2012
Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous systemJana Zdarova Karasova, Filip Zemek, Kamil Musilek, et al.
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Medicinal Research Reviews|October 29, 2025
Human Cyclophilins-An Emerging Class of Drug TargetsKatarina Jurkova, Hana Navratilova, Kamil Musilek, et al.
Medicinal Research Reviews|June 15, 2026
Small-Molecule Kinase Inhibitors Modulating Circadian RhythmsIrene Castellino, Manuela Bartolini, Rudolf Andrys, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 30, 2006
New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarinMartina Hrabinova, Kamil Musilek, Daniel Jun, et al.
Journal of Separation Science|August 22, 2014
Structural modifications of dicationic acetylcholinesterase reactivators studied under ion-pairing mechanism in reversed-phase liquid chromatographyMedeea Radulescu, Kamil Kuca, Kamil Musilek, et al.
Behavioural Brain Research|March 18, 2014
Cholinergic antagonist 3-quinuclidinyl benzilate - Impact on learning and memory in Wistar ratsJan Misik, Jan Vanek, Kamil Musilek, et al.
Toxicology Mechanisms and Methods|August 21, 2012
The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and miceJiri Kassa, Vendula Sepsova, Kamil Musilek, et al.
Expert Opinion on Drug Discovery|September 28, 2012
The progress in the cholinesterase quantification methodsOndrej Holas, Kamil Musilek, Miroslav Pohanka, et al.
Medicinal Research Reviews|December 23, 2009
Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticidesKamil Musilek, Martin Dolezal, Frank Gunn-Moore, et al.
Drug and Chemical Toxicology|May 1, 2010
A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and miceJiri Kassa, Jana Zdarova Karasova, Kamil Kuca, et al.
Neurotoxicity Research|May 16, 2012
Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous systemJana Zdarova Karasova, Filip Zemek, Kamil Musilek, et al.
Pageof 20